About Pharma Diagnostics
Pharma Diagnostics is a company based in Asse (Belgium) founded in 2007. Pharma Diagnostics has raised $7.4 million across 2 funding rounds from investors including PMV, Cap-E and Capital E. The company has 8 employees as of December 31, 2015. Pharma Diagnostics operates in a competitive market with competitors including Carterra, Nicoya Life, Riot Platforms, FOx Biosystems and Plasmore, among others.
- Headquarter Asse, Belgium
- Employees 8 as on 31 Dec, 2015
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pharma Diagnostics
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.4 M (USD)
in 2 rounds
-
Latest Funding Round
$3.7 M (USD), Series B
Jan 21, 2010
-
Investors
PMV
& 3 more
-
Employee Count
8
as on Dec 31, 2015
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Pharma Diagnostics
Pharma Diagnostics has successfully raised a total of $7.4M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $3.7 million completed in January 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Pharma Diagnostics
Pharma Diagnostics has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include PMV, Cap-E and Capital E.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US focused early-stage VC firm
|
Locked | Locked | Locked | |
|
A venture capital fund focused on micro/nano-electronics is operated.
|
Locked | Locked | Locked | |
|
Allegro Investment Fund is involved in investment activities.
|
Locked | Locked | Locked |
Investor details for Pharma Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pharma Diagnostics
Investment portfolio details for Pharma Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pharma Diagnostics
Detailed financials for Pharma Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pharma Diagnostics Comparisons
Peer comparison for Pharma Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pharma Diagnostics
Pharma Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Carterra, Nicoya Life, Riot Platforms, FOx Biosystems and Plasmore, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
SPR-based platforms are developed for enzyme kinetics studies.
|
|
| Locked | Locked | Locked |
Hyperspectral optical microscopes for surface analysis are provided.
|
|
| Locked | Locked | Locked |
Bitcoin mining solutions are offered by the platform.
|
|
| Locked | Locked | Locked |
Developer of fiber optic bio-sensing technology based on surface plasmon resonance
|
|
| Locked | Locked | Locked |
Develops nanoplasmon imaging technology
|
Detailed competitors of Pharma Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pharma Diagnostics
Complete news archive for Pharma Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pharma Diagnostics
Pharma Diagnostics was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Pharma Diagnostics is headquartered in Asse, Belgium. It is registered at Asse, Flemish Brabant, Belgium.
Pierre Saelen is the current CEO of Pharma Diagnostics.
Pharma Diagnostics is a funded company, having raised a total of $7.4M across 2 funding rounds to date.
As of Dec 31, 2015, the latest employee count at Pharma Diagnostics is 8.
Pharma Diagnostics was founded in 2007 in Asse, Belgium, and operates in the diagnostics sector. A technology platform for biomolecular interaction analysis is offered, centered on the proprietary SoPRano assay. This plate-based LSPR method employs gold nanomaterials conjugated to biomolecules, with absorbance changes detected on standard plate readers upon ligand binding. Applications encompass interaction kinetics, antibody screening, protein-protein interaction studies, and small molecule inhibition assays.
Pharma Diagnostics's top competitors include Carterra, Nicoya Life and Riot Platforms.
Pharma Diagnostics has 4 investors. Key investors include PMV, Cap-E, Capital E, and Allegro Investment Fund.